Carine S Abi Gerges, Courtney M Rowan, Francis Pike, Daniel T Cater
{"title":"Abnormal Platelet-to-Lymphocyte Ratio is Associated with Poor Outcomes in Pediatric Sepsis.","authors":"Carine S Abi Gerges, Courtney M Rowan, Francis Pike, Daniel T Cater","doi":"10.1097/SHK.0000000000002681","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Sepsis remains a major cause of morbidity and mortality in children, necessitating an early risk assessment to prevent delayed treatment and achieve optimal outcomes. This study investigated the association between systemic immune-inflammatory indices and clinical outcomes in children with sepsis.</p><p><strong>Design: </strong>Single-center, retrospective cohort study.</p><p><strong>Setting: </strong>Pediatric intensive Care Unit (PICU) of a tertiary care children's hospital from 2015 to 2023.</p><p><strong>Patients: </strong>Children aged 0-18 years admitted with sepsis. Patients were excluded if they lacked a complete blood count with differential on admission.</p><p><strong>Results: </strong>420 patients were included. The platelet-to-lymphocyte ratio (PLR) was associated with higher mortality [HR:1.001 (1.000-1.002), p:0.032]. Incorporating PLR into the Pediatric Index of Mortality (PIM) score improved the model discrimination for mortality (AUROC 0.705 vs. 0.774; AUPRC 0.202 vs 0.257). Similarly, adding PLR to the PRISM-III improved AUROC from 0.648 to 0.697. High PLR was also associated with higher odds of requiring intubation (OR 2.42, p:0.005) and extracorporeal membrane oxygenation (OR 4.74, p:0.002) and with decreased sub distribution hazard of extubation, ICU discharge, and hospital discharge alive at 28 days (SHR: 0.89, 0.72, and 0.76 respectively; all p < 0.005).</p><p><strong>Conclusions: </strong>High PLR at admission was independently associated with worse clinical outcomes in pediatric patients with sepsis. Adding PLR to PIM and PRISM III enhanced the predictive performance. PLR is a simple and readily available index that may improve early risk stratification in this high-risk population.</p>","PeriodicalId":21667,"journal":{"name":"SHOCK","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SHOCK","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SHK.0000000000002681","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Sepsis remains a major cause of morbidity and mortality in children, necessitating an early risk assessment to prevent delayed treatment and achieve optimal outcomes. This study investigated the association between systemic immune-inflammatory indices and clinical outcomes in children with sepsis.
Setting: Pediatric intensive Care Unit (PICU) of a tertiary care children's hospital from 2015 to 2023.
Patients: Children aged 0-18 years admitted with sepsis. Patients were excluded if they lacked a complete blood count with differential on admission.
Results: 420 patients were included. The platelet-to-lymphocyte ratio (PLR) was associated with higher mortality [HR:1.001 (1.000-1.002), p:0.032]. Incorporating PLR into the Pediatric Index of Mortality (PIM) score improved the model discrimination for mortality (AUROC 0.705 vs. 0.774; AUPRC 0.202 vs 0.257). Similarly, adding PLR to the PRISM-III improved AUROC from 0.648 to 0.697. High PLR was also associated with higher odds of requiring intubation (OR 2.42, p:0.005) and extracorporeal membrane oxygenation (OR 4.74, p:0.002) and with decreased sub distribution hazard of extubation, ICU discharge, and hospital discharge alive at 28 days (SHR: 0.89, 0.72, and 0.76 respectively; all p < 0.005).
Conclusions: High PLR at admission was independently associated with worse clinical outcomes in pediatric patients with sepsis. Adding PLR to PIM and PRISM III enhanced the predictive performance. PLR is a simple and readily available index that may improve early risk stratification in this high-risk population.
期刊介绍:
SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Making such information available will ultimately facilitate improved care of the traumatized or septic individual.